These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 28408014)

  • 1. Cost-Effectiveness Thresholds in Global Health: Taking a Multisectoral Perspective.
    Remme M; Martinez-Alvarez M; Vassall A
    Value Health; 2017 Apr; 20(4):699-704. PubMed ID: 28408014
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Financing intersectoral action for health: a systematic review of co-financing models.
    McGuire F; Vijayasingham L; Vassall A; Small R; Webb D; Guthrie T; Remme M
    Global Health; 2019 Dec; 15(1):86. PubMed ID: 31849335
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Financing structural interventions: going beyond HIV-only value for money assessments.
    Remme M; Vassall A; Lutz B; Luna J; Watts C
    AIDS; 2014 Jan; 28(3):425-34. PubMed ID: 24670525
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Public health services and systems research: an agenda where research and practice matter to each other and to our nation's health.
    Larkin MA; Marks JS
    Am J Prev Med; 2012 May; 42(5 Suppl 1):S79-81. PubMed ID: 22502929
    [No Abstract]   [Full Text] [Related]  

  • 5. Principles of good practice for budget impact analysis: report of the ISPOR Task Force on good research practices--budget impact analysis.
    Mauskopf JA; Sullivan SD; Annemans L; Caro J; Mullins CD; Nuijten M; Orlewska E; Watkins J; Trueman P
    Value Health; 2007; 10(5):336-47. PubMed ID: 17888098
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Budget impact analysis-principles of good practice: report of the ISPOR 2012 Budget Impact Analysis Good Practice II Task Force.
    Sullivan SD; Mauskopf JA; Augustovski F; Jaime Caro J; Lee KM; Minchin M; Orlewska E; Penna P; Rodriguez Barrios JM; Shau WY
    Value Health; 2014; 17(1):5-14. PubMed ID: 24438712
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of a population-based cost-effectiveness model of chronic graft-versus-host disease in Spain.
    Crespo C; Pérez-Simón JA; Rodríguez JM; Sierra J; Brosa M
    Clin Ther; 2012 Aug; 34(8):1774-87. PubMed ID: 22835778
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Matching taxpayer funding to population health needs.
    Hanna M
    Circ Res; 2015 Apr; 116(8):1296-300. PubMed ID: 25858062
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Economics, public health and health care purchasing: reinventing the wheel?
    Donaldson C
    Health Policy; 1995 Aug; 33(2):79-90. PubMed ID: 10144440
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A note on the depreciation of the societal perspective in economic evaluation of health care.
    Johannesson M
    Health Policy; 1995 Jul; 33(1):59-66. PubMed ID: 10143700
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discounting in cost-utility analysis of healthcare interventions: reassessing current practice.
    Cohen BJ
    Pharmacoeconomics; 2003; 21(2):75-87. PubMed ID: 12515570
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tools of the trade: a comparative analysis of approaches to priority setting in healthcare.
    Mitton C; Donaldson C
    Health Serv Manage Res; 2003 May; 16(2):96-105. PubMed ID: 12803949
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost-effectiveness thresholds in health care: a bookshelf guide to their meaning and use.
    Culyer AJ
    Health Econ Policy Law; 2016 Oct; 11(4):415-32. PubMed ID: 26906561
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The potential to forgo social welfare gains through overrelianceon cost effectiveness/cost utility analyses in the evidence base for public health.
    Cohen DR; Patel N
    J Environ Public Health; 2009; 2009():107927. PubMed ID: 20049165
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of budget impact in drug reimbursement decisions.
    Cohen JP; Stolk E; Niezen M
    J Health Polit Policy Law; 2008 Apr; 33(2):225-47. PubMed ID: 18325899
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Implementing and using quality measures for children's health care: perspectives on the state of the practice.
    Shaller D
    Pediatrics; 2004 Jan; 113(1 Pt 2):217-27. PubMed ID: 14702504
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Determinants of Change in the Cost-effectiveness Threshold.
    Paulden M; O'Mahony J; McCabe C
    Med Decis Making; 2017 Feb; 37(2):264-276. PubMed ID: 27553208
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Social Return on Investment: Valuing health outcomes or promoting economic values?
    Leck C; Upton D; Evans N
    J Health Psychol; 2016 Jul; 21(7):1481-90. PubMed ID: 25432458
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Specific considerations for research on the effectiveness of multisectoral collaboration: methods and lessons from 12 country case studies.
    Hinton R; Armstrong C; Asri E; Baesel K; Barnett S; Blauvelt C; Buang SNB; Bury L; Das JK; Franz-Vasdeki J; Milman HM; Murray J; Palma S; Renner I; Roche M; Saint V; Simpson S; Singh L; McGhie DV; Ukhova D; van Dijk J; Xinico S; Fogstad H; Graham W; Kuruvilla S
    Global Health; 2021 Feb; 17(1):18. PubMed ID: 33522937
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.